Follow the RaySearch Laboratories AB (publ) stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, RaySearch Laboratories AB (publ) has logged 15 insider filings. Market capitalisation: €7.9bn. The latest transaction was reported on 16 June 2026 (Purchase). Among the most active insiders: Peter Kemlin. The full history is free.
15
Insider Decl.
0
Thresholds
€549,163
13 ops.
Buy Volume
€149,681
2 ops.
Sell Volume
32Σ signal
Buys €549,163€149,681 Sells
Fundamental score
Ranked 5,388 of 25,927 companies
66.4
score / 100
Value
47
Quality
86
FCF yld2.1%
Earn yld2.9%
EV/EBITDA13.8x
ROE23%
Gross mgn92%
Net mgn17%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5,500 shares@ €21.36890.0019% mcap100.0% of flowAktieFI:A003M831-1
15 of 15 declarations
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ) is a Swedish company that develops software for radiation therapy. It is listed on the Stockholm Stock Exchange (XSTO).